Versant Vantage II GP-GP, LLC sold $10.3M of LENZ Therapeutics (LENZ)

Executed Sep 30 2025, disclosed Oct 2 2025, 2 days later.

Value, as filed

$10.3M

224,674 sh across 4 lots

Executed

Sep 30 2025

the trade date, as filed

Disclosed

Oct 2 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

VL Versant Vantage II GP-GP, LLC 10% owner profile →

Versant Vantage II GP-GP, LLC (10% owner) filed 1 Form 4 report as a reporting entity in the trailing twelve months (0 purchases, 1 sale), most often in LENZ. The largest single filing was $10.3M of LENZ (224,674 sh across 4 lots, as filed), executed Sep 30 2025.

The name

LENZ LENZ LENZ · 11 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Versant Vantage II GP-GP, LLC in LENZ

LENZSALE LENZ Therapeutics, Inc. $6.1M
200,000 sh × $30.47
Exec Jun 27 2025
Filed Jul 1 2025 · 5:30 PM ET LENZSALE LENZ Therapeutics, Inc. $10.2M
350,000 sh × $29.00
Exec Jun 10 2025
Filed Jun 12 2025 · 5:30 PM ET